相似文献
1
Harnessing the Prokaryotic Adaptive Immune System as a Eukaryotic Antiviral Defense.
Trends Microbiol. 2016 Apr;24(4):294-306. doi: 10.1016/j.tim.2016.01.005. Epub 2016 Feb 3.
2
Antiviral Goes Viral: Harnessing CRISPR/Cas9 to Combat Viruses in Humans.
Trends Microbiol. 2017 Oct;25(10):833-850. doi: 10.1016/j.tim.2017.04.005. Epub 2017 May 15.
3
CRISPR-Cas systems: Prokaryotes upgrade to adaptive immunity.
Mol Cell. 2014 Apr 24;54(2):234-44. doi: 10.1016/j.molcel.2014.03.011.
4
Adaptation in CRISPR-Cas Systems.
Mol Cell. 2016 Mar 17;61(6):797-808. doi: 10.1016/j.molcel.2016.01.030. Epub 2016 Mar 3.
5
United we stand: big roles for small RNA gene clusters.
RNA. 2017 Feb;23(2):131-133. doi: 10.1261/rna.058891.116. Epub 2016 Nov 23.
6
Therapeutic Strategies of Clustered Regularly Interspaced Palindromic Repeats-Cas Systems for Different Viral Infections.
Viral Immunol. 2017 Oct;30(8):552-559. doi: 10.1089/vim.2017.0055. Epub 2017 Aug 21.
7
[Clustered regularly interspaced short palindromic repeats: structure, function and application--a review].
Wei Sheng Wu Xue Bao. 2008 Nov;48(11):1549-55.
8
Advances with using CRISPR/Cas-mediated gene editing to treat infections with hepatitis B virus and hepatitis C virus.
Virus Res. 2018 Jan 15;244:311-320. doi: 10.1016/j.virusres.2017.01.003. Epub 2017 Jan 10.
9
Cas9-mediated targeting of viral RNA in eukaryotic cells.
Proc Natl Acad Sci U S A. 2015 May 12;112(19):6164-9. doi: 10.1073/pnas.1422340112. Epub 2015 Apr 27.
10
Prokaryotic homologs of Argonaute proteins are predicted to function as key components of a novel system of defense against mobile genetic elements.
Biol Direct. 2009 Aug 25;4:29. doi: 10.1186/1745-6150-4-29.
引用本文的文献
1
Engineering CRISPR immune systems conferring GLRaV-3 resistance in grapevine.
Hortic Res. 2022 Jan 18;9. doi: 10.1093/hr/uhab023.
2
Genome-editing approaches and applications: a brief review on CRISPR technology and its role in cancer.
3 Biotech. 2021 Mar;11(3):146. doi: 10.1007/s13205-021-02680-4. Epub 2021 Feb 26.
3
Production of CFTR-ΔF508 Rabbits.
Front Genet. 2021 Jan 22;11:627666. doi: 10.3389/fgene.2020.627666. eCollection 2020.
4
CRISPR-Cas13d mediates robust RNA virus interference in plants.
Genome Biol. 2019 Dec 2;20(1):263. doi: 10.1186/s13059-019-1881-2.
5
Engineering plant virus resistance: from RNA silencing to genome editing strategies.
Plant Biotechnol J. 2020 Feb;18(2):328-336. doi: 10.1111/pbi.13278. Epub 2019 Nov 6.
6
CRISPR/Cas9-mediated resistance to cauliflower mosaic virus.
Plant Direct. 2018 Mar 7;2(3):e00047. doi: 10.1002/pld3.47. eCollection 2018 Mar.
7
HIV-1 Employs Multiple Mechanisms To Resist Cas9/Single Guide RNA Targeting the Viral Primer Binding Site.
J Virol. 2018 Sep 26;92(20). doi: 10.1128/JVI.01135-18. Print 2018 Oct 15.
8
Establishing RNA virus resistance in plants by harnessing CRISPR immune system.
Plant Biotechnol J. 2018 Aug;16(8):1415-1423. doi: 10.1111/pbi.12881. Epub 2018 Feb 14.
9
Antiviral Defenses in Plants through Genome Editing.
Front Microbiol. 2017 Jan 23;8:47. doi: 10.3389/fmicb.2017.00047. eCollection 2017.
10
Gene Editing Approaches against Viral Infections and Strategy to Prevent Occurrence of Viral Escape.
PLoS Pathog. 2016 Dec 8;12(12):e1005953. doi: 10.1371/journal.ppat.1005953. eCollection 2016 Dec.
本文引用的文献
1
Conferring resistance to geminiviruses with the CRISPR-Cas prokaryotic immune system.
Nat Plants. 2015 Oct;1(10). doi: 10.1038/nplants.2015.145. Epub 2015 Sep 28.
2
Establishing a CRISPR-Cas-like immune system conferring DNA virus resistance in plants.
Nat Plants. 2015 Sep 28;1:15144. doi: 10.1038/nplants.2015.144.
3
High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects.
Nature. 2016 Jan 28;529(7587):490-5. doi: 10.1038/nature16526. Epub 2016 Jan 6.
4
Specific induction of endogenous viral restriction factors using CRISPR/Cas-derived transcriptional activators.
Proc Natl Acad Sci U S A. 2015 Dec 29;112(52):E7249-56. doi: 10.1073/pnas.1516305112. Epub 2015 Dec 14.
5
Rationally engineered Cas9 nucleases with improved specificity.
Science. 2016 Jan 1;351(6268):84-8. doi: 10.1126/science.aad5227. Epub 2015 Dec 1.
6
CRISPR-mediated Activation of Latent HIV-1 Expression.
Mol Ther. 2016 Mar;24(3):499-507. doi: 10.1038/mt.2015.213. Epub 2015 Nov 26.
7
Potent and Targeted Activation of Latent HIV-1 Using the CRISPR/dCas9 Activator Complex.
Mol Ther. 2016 Mar;24(3):488-98. doi: 10.1038/mt.2015.202. Epub 2015 Nov 19.
8
CRISPR/Cas9-mediated viral interference in plants.
Genome Biol. 2015 Nov 11;16:238. doi: 10.1186/s13059-015-0799-6.
9
CRISPR/gRNA-directed synergistic activation mediator (SAM) induces specific, persistent and robust reactivation of the HIV-1 latent reservoirs.
Sci Rep. 2015 Nov 5;5:16277. doi: 10.1038/srep16277.
10
Surface-Engineered Viral Vectors for Selective and Cell Type-Specific Gene Delivery.
Trends Biotechnol. 2015 Dec;33(12):777-790. doi: 10.1016/j.tibtech.2015.09.008. Epub 2015 Oct 20.
Zotero 插件